Health Condition 1: N943- Premenstrual tension syndrome
Conditions
Interventions
Intervention1: Brinjasif: Brinjasif will be finely powdered and 2 capsules of 500mg TID will be administered orally for 13days 2 consecutive cycles (from 21st day of menstrual cycle to 3rd day of next
Sponsors
Luqman Unani Medical College Hospital and Research Centre
Eligibility
Inclusion criteria
Inclusion criteria: 1) Subject irrespective of their marital status, between 18-40 years having regular menstrual cycle of 21-35days. 2) Presenting with signs and symptoms of PMS for atleast 3 menstrual cycles as per ACOG guidelines.
Exclusion criteria
Exclusion criteria: Patients with 1) Irregular menstrual cycle. 2) Pregnancy, lactating and women on OCPs, HRT. 3) Diagnosed case of psychiatric disease. 4) Women with uncontrolled endocrine illness (DM, THYROID DISEASE, HTN).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in PMTS-O scale before and after the treatment.Timepoint: will be assessed at the baseline cycle during the treatment for the next consecutive treatment and after the treatment for one cycle | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in VAS scale before & after the treatment.Timepoint: will be assessed at the baseline cycle during the treatment for the next consecutive treatment & after the treatment for one cycle | — |
Countries
India
Contacts
Public ContactDr Nikhat Kausar Inamdar
Luqman Unani Medical College Hospital and Research Centre
Outcome results
None listed